‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
Article in Advances in Therapy (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Advances in Therapy (March 2024)
Article in Critical Reviews in Oncology/Hematology (February 2024)
Article in Current Gastroenterology Reports (January 2024)